Moderna, Inc. Director Noubar B. Afeyan is set to sell 15,000 shares of the company's common stock on 04/24/2024, with an aggregate market value of $1,618,350. The shares were originally acquired on 05/01/2012 through a private placement from the issuer. This upcoming sale follows a series of transactions over the past three months where Afeyan sold a total of 90,000 shares, generating gross proceeds of $9,482,551.50. The notice of the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 11/07/2023.

Moderna, Inc. Director Noubar B. Afeyan is set to sell 15,000 shares of the company's common stock on 04/24/2024, with an aggregate market value of $1,618,350. The shares were originally acquired on 05/01/2012 through a private placement from the issuer. This upcoming sale follows a series of transactions over the past three months where Afeyan sold a total of 90,000 shares, generating gross proceeds of $9,482,551.50. The notice of the planned sale was filed on the same date as the sale, with the plan for this transaction having been adopted on 11/07/2023.